Dr. Jacqueline R. Carrasco, MD

Dr. Carrasco practices at Lankenau Medical Center in Wayne, Pennsylvania.

Dr. Carrasco's NPI, 1336148410, was assigned on July 20, 2005. Dr. Carrasco graduated from University of Miami, Miller School of Medicine in 1999. Dr. Carrasco holds Pennsylvania license MD416985.

Dr. Carrasco's primary practice is Lankenau Medical Center, at 100 E Lancaster Ave, Wayne, PA 19087 in Delaware County. The practice phone is (610) 645-2000.

Dr. Carrasco's primary practice is Lankenau Medical Center in Wayne, Pennsylvania. Dr. Carrasco is also affiliated with Lankenau Medical Center. Dmand AI also links Dr. Carrasco to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carrasco practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Carrasco's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Carrasco is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Carrasco's licenses on file in 2 states: Pennsylvania and New Jersey.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma, hereditary corneal conditions and secondary membranaous cataract surgery among the conditions Dr. Carrasco treats.

CMS data shows 9,168 Medicare services from Dr. Carrasco across 27 procedure codes in 2024, for 594 Medicare patients. Medicare paid $276,751 for them.

CMS counts 594 Medicare patients who saw Dr. Carrasco in 2024. The largest group is 65 to 74, with 286 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carrasco's median patient age at 70, with 72% women.

In 2024, Dr. Carrasco wrote 1,090 Medicare Part D claims for 386 patients. 60% of them were for generic drugs. CMS names the drug for 1,009 of them, across 15 drugs with 11 or more claims each, at $94,769 in total drug cost. In 2023, CMS named 959 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Carrasco for performance year 2024, reported as part of a group. Dr. Carrasco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of melanoma (skin cancer) excision by Dr. Carrasco, more than 80% of the clinicians it reports for that procedure.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Carrasco, published from 2013 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Orbit, Diagnosis, Differential and Magnetic Resonance Imaging. Dr. Carrasco has published most often in Orbit. Dr. Carrasco's most frequent co-authors are Michael Paul Rabinowitz, MD, Ralph C. Eagle, MD and Tatyana Milman, MD.

CMS Open Payments shows 213 general payments to Dr. Carrasco from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Horizon Pharma plc paid the most, $36,153.

Dmand AI lists 9 awards for Dr. Carrasco, most recently Castle Connolly Top Doctor in Oculoplastic Surgery/ Ophthalmology in 2025.

Dr. Carrasco graduated from University of Miami, Miller School of Medicine in 1999. Dr. Carrasco is a member of AAO, ACS and American Society of Ophthalmic Plastic and Reconstructive Surgery.

Dr. Carrasco is in network with 20 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.